We are live on ! Find out more
VAXX

Vaxxinity, Inc. Class A Common Stock
VAXX

Delisted

VAXX was delisted on the 8th of May, 2024.

Back to rankings

8 hedge funds and large institutions have $67.8K invested in Vaxxinity, Inc. Class A Common Stock in 2024 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 2

86% less funds holding

Funds holding: 58 → 8 (-50)

99% less capital invested

Capital invested by funds: $8.73M → $67.8K (-$8.66M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 50

Holders
8
Holders Change
-50
Holders Change %
-86.21%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
2
Reduced
2
Closed
50
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SWM
Spire Wealth Management
Virginia
+$56.8K
2
XT
XTX Topco
Cayman Islands
+$17.9K

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$2.15M
2
BlackRock
BlackRock
New York
-$1.88M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$1.73M
4
Geode Capital Management
Geode Capital Management
Massachusetts
-$630K
5
State Street
State Street
Massachusetts
-$573K

VAXX Hedge Fund Activity: Q2 2024 in Review

8 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q2 2024, worth a combined $67.8K — down 99% from $8.73M a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of VAXX and 0 opened new positions — a net loss of 50 holders — while 2 trimmed existing stakes and 2 added.

The largest buyer was Spire Wealth Management, adding an estimated $56.8K. The largest seller was Adage Capital Partners, exiting entirely with an estimated $2.15M sold.

  • 8 institutional investors held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q2 2024, down from 58 in Q1 2024.
  • Funds reported $67.8K of Vaxxinity, Inc. Class A Common Stock stock for Q2 2024, down 99% quarter-over-quarter.
  • 0 funds opened new Vaxxinity, Inc. Class A Common Stock positions in Q2 2024 and 50 closed out, a net change of -50 holders.
  • The largest Vaxxinity, Inc. Class A Common Stock buyer in Q2 2024 was Spire Wealth Management, an estimated $56.8K added.
  • The largest Vaxxinity, Inc. Class A Common Stock seller in Q2 2024 was Adage Capital Partners, an estimated $2.15M sold.

Based on aggregated 13F filings for Q2 2024.